GO ID | GO:0007165 |
Ontology | BP |
GO Term | signal transduction |
Definition | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
ARHGAP42 |
Rho GTPase activating protein 42 |
143872 |
A6NI28 |
chr11: 100,687,653-100,991,937 |
GPR89A |
G protein-coupled receptor 89A |
653519 |
B7ZAQ6 |
chr1: 145,607,990-145,670,648 |
AIP |
aryl hydrocarbon receptor interacting protein |
9049 |
O00170 |
chr11: 67,483,041-67,491,103 |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
322 |
O00213 |
chr11: 6,395,124-6,419,414 |
CLIC1 |
chloride intracellular channel 1 |
1192 |
O00299 |
chr6: 31,730,581-31,739,763 |
TNFRSF11B |
tumor necrosis factor receptor superfamily member 11b |
4982 |
O00300 |
chr8: 118,923,557-118,952,200 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
CHL1 |
cell adhesion molecule L1-like |
10752 |
O00533 |
chr3: 196,596-409,417 |
CLDN4 |
claudin 4 |
1364 |
O14493 |
chr7: 73,799,542-73,832,693 |
IRS4 |
insulin receptor substrate 4 |
8471 |
O14654 |
chrX: 108,732,482-108,736,409 |
PTGES |
prostaglandin E synthase |
9536 |
O14684 |
chr9: 129,738,331-129,753,047 |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
5609 |
O14733 |
chr19: 7,903,843-7,914,478 |
NRP1 |
neuropilin 1 |
8829 |
O14786 |
chr10: 33,177,492-33,336,262 |
TNFRSF10C |
tumor necrosis factor receptor superfamily member 10c |
8794 |
O14798 |
chr8: 23,084,355-23,117,437 |
MGST3 |
microsomal glutathione S-transferase 3 |
4259 |
O14880 |
chr1: 165,630,861-165,661,796 |
RGS12 |
regulator of G-protein signaling 12 |
6002 |
O14924 |
chr4: 3,293,028-3,439,913 |
PPP1R12A |
protein phosphatase 1 regulatory subunit 12A |
4659 |
O14974 |
chr12: 79,773,563-79,935,460 |
FYB |
FYN binding protein |
2533 |
O15117 |
chr5: 39,105,236-39,274,528 |
NPC1 |
Niemann-Pick disease, type C1 |
4864 |
O15118 |
chr18: 23,506,184-23,586,898 |
ANGPT2 |
angiopoietin 2 |
285 |
O15123 |
chr8: 6,499,651-6,563,409 |
NPHP1 |
nephronophthisis 1 (juvenile) |
4867 |
O15259 |
chr2: 110,122,311-110,205,066 |
OGT |
O-linked N-acetylglucosamine (GlcNAc) transferase |
8473 |
O15294 |
chrX: 71,533,083-71,575,897 |
INPP4B |
inositol polyphosphate-4-phosphatase type II B |
8821 |
O15327 |
chr4: 142,023,160-142,847,432 |
TLR3 |
toll-like receptor 3 |
7098 |
O15455 |
chr4: 186,069,152-186,088,069 |
CAPN5 |
calpain 5 |
726 |
O15484 |
chr11: 77,066,932-77,126,155 |
CLDN3 |
claudin 3 |
1365 |
O15551 |
chr7: 73,768,997-73,770,270 |
RIPK2 |
receptor interacting serine/threonine kinase 2 |
8767 |
O43353 |
chr8: 89,757,747-89,791,063 |
AKAP10 |
A-kinase anchoring protein 10 |
11216 |
O43572 |
chr17: 19,904,302-19,978,343 |
TYROBP |
TYRO protein tyrosine kinase binding protein |
7305 |
O43914 |
chr19: 35,904,401-35,908,295 |
PPP1R12B |
protein phosphatase 1 regulatory subunit 12B |
4660 |
O60237 |
chr1: 202,348,699-202,592,706 |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
9467 |
O60239 |
chr3: 15,254,853-15,341,368 |
ADCY3 |
adenylate cyclase 3 |
109 |
O60266 |
chr2: 24,819,169-24,919,839 |
LY75 |
lymphocyte antigen 75 |
4065 |
O60449 |
chr2: 159,803,355-159,904,749 |
ADCY9 |
adenylate cyclase 9 |
115 |
O60503 |
chr16: 3,953,387-4,116,185 |
CREBL2 |
cAMP responsive element binding protein-like 2 |
1389 |
O60519 |
chr12: 12,611,827-12,645,108 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
26585 |
O60565 |
chr15: 32,717,974-32,745,107 |
TLR2 |
toll-like receptor 2 |
7097 |
O60603 |
chr4: 153,701,500-153,705,699 |
PDE8A |
phosphodiesterase 8A |
5151 |
O60658 |
chr15: 84,980,440-85,139,145 |
JAK2 |
Janus kinase 2 |
3717 |
O60674 |
chr9: 4,984,390-5,128,183 |
LPXN |
leupaxin |
9404 |
O60711 |
chr11: 58,526,871-58,578,220 |
TRIM13 |
tripartite motif containing 13 |
10206 |
O60858 |
chr13: 49,995,888-50,020,481 |
ZPR1 |
ZPR1 zinc finger |
8882 |
O75312 |
chr11: 116,773,799-116,788,050 |
ZNF217 |
zinc finger protein 217 |
7764 |
O75362 |
chr20: 53,567,065-53,609,907 |
FLNB |
filamin B |
2317 |
O75369 |
chr3: 58,008,400-58,172,251 |
ULK1 |
unc-51 like autophagy activating kinase 1 |
8408 |
O75385 |
chr12: 131,894,651-131,923,167 |
SKAP2 |
src kinase associated phosphoprotein 2 |
8935 |
O75563 |
chr7: 26,667,062-26,995,239 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
8412 |
O75815 |
chr1: 93,561,786-93,847,150 |
TNFSF13 |
tumor necrosis factor superfamily member 13 |
8741 |
O75888 |
chr17: 7,558,292-7,561,608 |
RASSF9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
9182 |
O75901 |
chr12: 85,800,697-85,836,570 |
PDE5A |
phosphodiesterase 5A |
8654 |
O76074 |
chr4: 119,494,395-119,628,991 |
WISP2 |
WNT1 inducible signaling pathway protein 2 |
8839 |
O76076 |
chr20: 44,714,844-44,728,509 |
PDE9A |
phosphodiesterase 9A |
5152 |
O76083 |
chr21: 42,653,636-42,775,509 |
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
PLEKHG5 |
pleckstrin homology and RhoGEF domain containing G5 |
57449 |
O94827 |
chr1: 6,466,092-6,520,061 |
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
10725 |
O94916 |
chr16: 69,565,094-69,704,666 |
FAM13A |
family with sequence similarity 13 member A |
10144 |
O94988 |
chr4: 88,725,955-89,111,398 |
IKBKAP |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
8518 |
O95163 |
chr9: 108,867,517-108,934,116 |
PDE8B |
phosphodiesterase 8B |
8622 |
O95263 |
chr5: 77,210,449-77,429,807 |
WISP1 |
WNT1 inducible signaling pathway protein 1 |
8840 |
O95388 |
chr8: 133,191,039-133,230,344 |
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
9547 |
O95715 |
chr5: 135,570,679-135,579,279 |
CLIC3 |
chloride intracellular channel 3 |
9022 |
O95833 |
chr9: 136,994,635-136,996,803 |
GUCA1C |
guanylate cyclase activator 1C |
9626 |
O95843 |
chr3: 108,907,792-108,953,895 |
PEX11B |
peroxisomal biogenesis factor 11 beta |
8799 |
O96011 |
chr1: 145,911,350-145,918,837 |
ACTL6A |
actin like 6A |
86 |
O96019 |
chr3: 179,562,880-179,588,408 |
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
PLAU |
plasminogen activator, urokinase |
5328 |
P00749 |
chr10: 73,909,177-73,917,497 |
C3 |
complement component 3 |
718 |
P01024 |
chr19: 6,677,704-6,730,562 |
GNRH1 |
gonadotropin releasing hormone 1 |
2796 |
P01148 |
chr8: 25,419,260-25,424,654 |
POMC |
proopiomelanocortin |
5443 |
P01189 |
chr2: 25,160,853-25,168,903 |
PENK |
proenkephalin |
5179 |
P01210 |
chr8: 56,436,674-56,446,734 |
CGA |
glycoprotein hormones, alpha polypeptide |
1081 |
P01215 |
chr6: 87,085,498-87,095,406 |
FSHB |
follicle stimulating hormone, beta polypeptide |
2488 |
P01225 |
chr11: 30,231,016-30,235,261 |
LHB |
luteinizing hormone beta polypeptide |
3972 |
P01229 |
chr19: 49,015,980-49,017,081 |
GCG |
glucagon |
2641 |
P01275 |
chr2: 162,142,873-162,152,404 |
IL1B |
interleukin 1 beta |
3553 |
P01584 |
chr2: 112,829,751-112,836,903 |
CD4 |
CD4 molecule |
920 |
P01730 |
chr12: 6,786,858-6,820,808 |
FGA |
fibrinogen alpha chain |
2243 |
P02671 |
chr4: 154,583,126-154,590,766 |
FGB |
fibrinogen beta chain |
2244 |
P02675 |
chr4: 154,562,956-154,571,086 |
FGG |
fibrinogen gamma chain |
2266 |
P02679 |
chr4: 154,604,134-154,612,967 |
ESR1 |
estrogen receptor 1 |
2099 |
P03372 |
chr6: 151,656,691-152,129,619 |
OPN1SW |
opsin 1 (cone pigments), short-wave-sensitive |
611 |
P03999 |
chr7: 128,772,491-128,775,790 |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
2908 |
P04150 |
chr5: 143,277,931-143,435,512 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
972 |
P04233 |
chr5: 150,401,637-150,412,929 |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
2771 |
P04899 |
chr3: 50,226,292-50,259,355 |
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
INHA |
inhibin alpha |
3623 |
P05111 |
chr2: 219,569,162-219,575,713 |
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
CCK |
cholecystokinin |
885 |
P06307 |
chr3: 42,257,825-42,266,207 |
PGR |
progesterone receptor |
5241 |
P06401 |
chr11: 101,029,624-101,130,524 |
S100A9 |
S100 calcium binding protein A9 |
6280 |
P06702 |
chr1: 153,357,854-153,361,027 |
S100A6 |
S100 calcium binding protein A6 |
6277 |
P06703 |
chr1: 153,534,599-153,536,244 |
NPM1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
4869 |
P06748 |
chr5: 171,387,116-171,411,137 |
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
LYN |
LYN proto-oncogene, Src family tyrosine kinase |
4067 |
P07948 |
chr8: 55,879,813-56,014,168 |
IGF1R |
insulin like growth factor 1 receptor |
3480 |
P08069 |
chr15: 98,648,971-98,964,530 |
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
ANXA5 |
annexin A5 |
308 |
P08758 |
chr4: 121,667,955-121,697,113 |
IGFBP1 |
insulin like growth factor binding protein 1 |
3484 |
P08833 |
chr7: 45,888,357-45,893,668 |
NMB |
neuromedin B |
4828 |
P08949 |
chr15: 84,655,129-84,658,563 |
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 |
P09341 |
chr4: 73,869,393-73,871,242 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
3956 |
P09382 |
chr22: 37,675,608-37,679,806 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
6678 |
P09486 |
chr5: 151,661,096-151,687,165 |
ANXA4 |
annexin A4 |
307 |
P09525 |
chr2: 69,644,425-69,827,100 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
GPR89B |
G protein-coupled receptor 89B |
51463 |
P0CG08 |
chr1: 147,928,393-147,993,521 |
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
AR |
androgen receptor |
367 |
P10275 |
chrX: 67,544,032-67,730,619 |
NR2F1 |
nuclear receptor subfamily 2 group F member 1 |
7025 |
P10589 |
chr5: 93,583,337-93,594,615 |
TXN |
thioredoxin |
7295 |
P10599 |
chr9: 110,243,811-110,256,640 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
IAPP |
islet amyloid polypeptide |
3375 |
P10997 |
chr12: 21,354,959-21,379,978 |
CHRNB1 |
cholinergic receptor, nicotinic beta 1 |
1140 |
P11230 |
chr17: 7,445,061-7,457,707 |
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
BCR |
breakpoint cluster region |
613 |
P11274 |
chr22: 23,179,704-23,318,037 |
VDR |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
7421 |
P11473 |
chr12: 47,841,537-47,943,048 |
IGF2R |
insulin like growth factor 2 receptor |
3482 |
P11717 |
chr6: 159,969,099-160,113,507 |
CDK4 |
cyclin-dependent kinase 4 |
1019 |
P11802 |
chr12: 57,747,727-57,756,013 |
FCGR1A |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 |
P12314 |
chr1: 149,782,671-149,792,518 |
CCL4 |
chemokine (C-C motif) ligand 4 |
6351 |
P13236 |
chr17: 36,103,590-36,105,621 |
CCL2 |
chemokine (C-C motif) ligand 2 |
6347 |
P13500 |
chr17: 34,255,218-34,257,203 |
HLA-DOB |
major histocompatibility complex, class II, DO beta |
3112 |
P13765 |
chr6: 32,812,763-32,817,048 |
JUP |
junction plakoglobin |
3728 |
P14923 |
chr17: 41,754,604-41,786,931 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 |
P15153 |
chr22: 37,225,261-37,244,448 |
IFNGR1 |
interferon gamma receptor 1 |
3459 |
P15260 |
chr6: 137,197,484-137,219,449 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
3096 |
P15822 |
chr6: 12,008,762-12,164,999 |
CREB1 |
cAMP responsive element binding protein 1 |
1385 |
P16220 |
chr2: 207,529,737-207,603,431 |
PECAM1 |
platelet/endothelial cell adhesion molecule 1 |
5175 |
P16284 |
chr17: 64,319,415-64,413,776 |
IL7R |
interleukin 7 receptor |
3575 |
P16871 |
chr5: 35,852,695-35,879,603 |
STMN1 |
stathmin 1 |
3925 |
P16949 |
chr1: 25,884,181-25,906,991 |
GJA1 |
gap junction protein alpha 1 |
2697 |
P17302 |
chr6: 121,435,692-121,449,727 |
IGFBP2 |
insulin like growth factor binding protein 2 |
3485 |
P18065 |
chr2: 216,632,828-216,664,436 |
ATF6 |
activating transcription factor 6 |
22926 |
P18850 |
chr1: 161,766,294-161,964,070 |
EPOR |
erythropoietin receptor |
2057 |
P19235 |
chr19: 11,377,205-11,384,342 |
CD53 |
CD53 molecule |
963 |
P19397 |
chr1: 110,873,154-110,899,928 |
FST |
follistatin |
10468 |
P19883 |
chr5: 53,480,409-53,487,134 |
CD33 |
CD33 molecule |
945 |
P20138 |
chr19: 51,225,064-51,243,860 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
1131 |
P20309 |
chr1: 239,386,565-239,915,452 |
TRH |
thyrotropin-releasing hormone |
7200 |
P20396 |
chr3: 129,974,305-129,977,938 |
CAPN3 |
calpain 3 |
825 |
P20807 |
chr15: 42,359,500-42,412,318 |
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1 |
5921 |
P20936 |
chr5: 87,267,888-87,391,931 |
FPR1 |
formyl peptide receptor 1 |
2357 |
P21462 |
chr19: 51,745,172-51,804,110 |
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
C5AR1 |
complement component 5a receptor 1 |
728 |
P21730 |
chr19: 47,290,023-47,322,066 |
MDK |
midkine (neurite growth-promoting factor 2) |
4192 |
P21741 |
chr11: 46,380,756-46,383,837 |
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
IGFBP4 |
insulin like growth factor binding protein 4 |
3487 |
P22692 |
chr17: 40,443,461-40,457,731 |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
3164 |
P22736 |
chr12: 52,022,832-52,059,507 |
EVI2A |
ecotropic viral integration site 2A |
2123 |
P22794 |
chr17: 31,317,560-31,321,884 |
MRC1 |
mannose receptor, C type 1 |
4360 |
P22897 |
chr10: 17,809,344-17,911,170 |
TNFSF4 |
tumor necrosis factor superfamily member 4 |
7292 |
P23510 |
chr1: 173,183,734-173,207,313 |
ITPKA |
inositol-trisphosphate 3-kinase A |
3706 |
P23677 |
chr15: 41,493,393-41,503,551 |
IL4R |
interleukin 4 receptor |
3566 |
P24394 |
chr16: 27,313,668-27,364,778 |
NR2F2 |
nuclear receptor subfamily 2 group F member 2 |
7026 |
P24468 |
chr15: 96,325,938-96,340,263 |
IGFBP6 |
insulin like growth factor binding protein 6 |
3489 |
P24592 |
chr12: 53,097,436-53,102,345 |
IGFBP5 |
insulin like growth factor binding protein 5 |
3488 |
P24593 |
chr2: 216,672,105-216,695,525 |
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
3579 |
P25025 |
chr2: 218,125,289-218,137,253 |
EDNRA |
endothelin receptor type A |
1909 |
P25101 |
chr4: 147,480,917-147,544,954 |
FAS |
Fas cell surface death receptor |
355 |
P25445 |
chr10: 88,990,582-89,015,785 |
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
GRN |
granulin |
2896 |
P28799 |
chr17: 44,345,086-44,353,102 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
5797 |
P28827 |
chr18: 7,566,782-8,406,861 |
TNFRSF8 |
tumor necrosis factor receptor superfamily member 8 |
943 |
P28908 |
chr1: 12,063,377-12,144,207 |
IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
3612 |
P29218 |
chr8: 81,657,961-81,686,693 |
LTK |
leukocyte receptor tyrosine kinase |
4058 |
P29376 |
chr15: 41,503,638-41,513,887 |
CASP1 |
caspase 1 |
834 |
P29466 |
chr11: 105,025,443-105,035,250 |
EEF1D |
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
1936 |
P29692 |
chr8: 143,579,697-143,599,541 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
2767 |
P29992 |
chr19: 3,094,410-3,124,004 |
PDIA3 |
protein disulfide isomerase family A member 3 |
2923 |
P30101 |
chr15: 43,746,392-43,773,279 |
CCND3 |
cyclin D3 |
896 |
P30281 |
chr6: 41,934,933-42,050,357 |
CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
1138 |
P30532 |
chr15: 78,565,520-78,595,269 |
TSPO |
translocator protein |
706 |
P30536 |
chr22: 43,151,514-43,163,242 |
ADORA1 |
adenosine A1 receptor |
134 |
P30542 |
chr1: 203,090,654-203,167,405 |
SRI |
sorcin |
6717 |
P30626 |
chr7: 88,205,118-88,226,993 |
NTS |
neurotensin |
4922 |
P30990 |
chr12: 85,874,295-85,882,992 |
GDI1 |
GDP dissociation inhibitor 1 |
2664 |
P31150 |
chrX: 154,436,913-154,443,467 |
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
SDC4 |
syndecan 4 |
6385 |
P31431 |
chr20: 45,325,288-45,348,424 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
3097 |
P31629 |
chr6: 142,751,467-142,956,698 |
GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
2558 |
P31644 |
chr15: 26,866,363-26,949,207 |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
SFN |
stratifin |
2810 |
P31947 |
chr1: 26,863,138-26,864,457 |
S100A11 |
S100 calcium binding protein A11 |
6282 |
P31949 |
chr1: 152,032,506-152,047,907 |
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 |
P31994 |
chr1: 161,663,147-161,678,654 |
STX2 |
syntaxin 2 |
2054 |
P32856 |
chr12: 130,789,600-130,839,266 |
LSP1 |
lymphocyte-specific protein 1 |
4046 |
P33241 |
chr11: 1,852,970-1,892,267 |
PHB |
prohibitin |
5245 |
P35232 |
chr17: 49,404,049-49,414,905 |
ADM |
adrenomedullin |
133 |
P35318 |
chr11: 10,304,680-10,307,397 |
ADRA1A |
adrenoceptor alpha 1A |
148 |
P35348 |
chr8: 26,748,150-26,867,273 |
IRS1 |
insulin receptor substrate 1 |
3667 |
P35568 |
chr2: 226,731,317-226,799,759 |
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
7075 |
P35590 |
chr1: 43,300,993-43,323,108 |
ADRBK2 |
adrenergic, beta, receptor kinase 2 |
157 |
P35626 |
chr22: 25,564,849-25,729,294 |
DEK |
DEK proto-oncogene |
7913 |
P35659 |
chr6: 18,223,868-18,264,823 |
CHKA |
choline kinase alpha |
1119 |
P35790 |
chr11: 68,052,859-68,121,444 |
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
1139 |
P36544 |
chr15: 31,923,438-32,173,018 |
ACVR1B |
activin A receptor type IB |
91 |
P36896 |
chr12: 51,951,667-51,997,078 |
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
GNL1 |
guanine nucleotide binding protein-like 1 |
2794 |
P36915 |
chr6: 30,541,377-30,557,174 |
LTBR |
lymphotoxin beta receptor |
4055 |
P36941 |
chr12: 6,375,045-6,391,571 |
PPARG |
peroxisome proliferator-activated receptor gamma |
5468 |
P37231 |
chr3: 12,287,368-12,434,356 |
COL15A1 |
collagen, type XV, alpha 1 |
1306 |
P39059 |
chr9: 98,943,179-99,070,792 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
2004 |
P41970 |
chr12: 96,194,382-96,269,835 |
ARHGAP25 |
Rho GTPase activating protein 25 |
9938 |
P42331 |
chr2: 68,679,601-68,826,833 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
ABL2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
27 |
P42684 |
chr1: 179,099,327-179,229,684 |
IL12RB1 |
interleukin 12 receptor subunit beta 1 |
3594 |
P42701 |
chr19: 18,058,995-18,098,944 |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
6374 |
P42830 |
chr4: 73,995,642-73,998,779 |
NR4A2 |
nuclear receptor subfamily 4 group A member 2 |
4929 |
P43354 |
chr2: 156,324,432-156,342,348 |
RANBP1 |
RAN binding protein 1 |
5902 |
P43487 |
chr22: 20,115,938-20,127,357 |
NAMPT |
nicotinamide phosphoribosyltransferase |
10135 |
P43490 |
chr7: 106,248,285-106,286,326 |
RANGAP1 |
Ran GTPase activating protein 1 |
5905 |
P46060 |
chr22: 41,245,611-41,286,251 |
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
8826 |
P46940 |
chr15: 90,388,218-90,502,243 |
OR3A3 |
olfactory receptor family 3 subfamily A member 3 |
8392 |
P47888 |
chr17: 3,411,370-3,424,070 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
6387 |
P48061 |
chr10: 44,370,165-44,386,493 |
SOX9 |
SRY-box 9 |
6662 |
P48436 |
chr17: 72,121,020-72,126,420 |
NMU |
neuromedin U |
10874 |
P48645 |
chr4: 55,595,229-55,636,698 |
CSNK1A1 |
casein kinase 1, alpha 1 |
1452 |
P48729 |
chr5: 149,492,197-149,551,552 |
CSNK1D |
casein kinase 1, delta |
1453 |
P48730 |
chr17: 82,239,023-82,273,731 |
INPP1 |
inositol polyphosphate-1-phosphatase |
3628 |
P49441 |
chr2: 190,343,470-190,371,665 |
CSNK1E |
casein kinase 1, epsilon |
1454 |
P49674 |
chr22: 38,290,691-38,318,084 |
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
HINT1 |
histidine triad nucleotide binding protein 1 |
3094 |
P49773 |
chr5: 131,159,027-131,171,735 |
GDI2 |
GDP dissociation inhibitor 2 |
2665 |
P50395 |
chr10: 5,765,223-5,842,132 |
TNFSF10 |
tumor necrosis factor superfamily member 10 |
8743 |
P50591 |
chr3: 172,505,508-172,523,507 |
BCAM |
basal cell adhesion molecule (Lutheran blood group) |
4059 |
P50895 |
chr19: 44,809,059-44,821,420 |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
3654 |
P51617 |
chrX: 154,010,500-154,019,980 |
CLCN6 |
chloride channel, voltage-sensitive 6 |
1185 |
P51797 |
chr1: 11,806,096-11,843,144 |
HDGF |
hepatoma-derived growth factor |
3068 |
P51858 |
chr1: 156,742,107-156,766,925 |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
5608 |
P52564 |
chr17: 69,414,698-69,543,331 |
RCAN1 |
regulator of calcineurin 1 |
1827 |
P53805 |
chr21: 34,513,142-34,615,142 |
YARS |
tyrosyl-tRNA synthetase |
8565 |
P54577 |
chr1: 32,775,237-32,818,153 |
PRKAG1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
5571 |
P54619 |
chr12: 49,002,274-49,019,197 |
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
5563 |
P54646 |
chr1: 56,645,322-56,715,335 |
GEM |
GTP binding protein overexpressed in skeletal muscle |
2669 |
P55040 |
chr8: 94,249,253-94,262,350 |
TPTE |
transmembrane phosphatase with tensin homology |
7179 |
P56180 |
chr21: 10,521,553-10,606,140 |
SOX8 |
SRY-box 8 |
30812 |
P57073 |
chr16: 981,808-986,979 |
RAP2B |
RAP2B, member of RAS oncogene family |
5912 |
P61225 |
chr3: 153,162,270-153,170,620 |
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2791 |
P61952 |
chr7: 93,921,699-93,928,610 |
RAP1A |
RAP1A, member of RAS oncogene family |
5906 |
P62834 |
chr1: 111,542,218-111,716,691 |
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
2782 |
P62873 |
chr1: 1,785,285-1,891,117 |
YWHAZ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
7534 |
P63104 |
chr8: 100,916,525-100,953,388 |
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
2787 |
P63218 |
chr1: 84,498,325-84,506,565 |
IGBP1 |
immunoglobulin (CD79A) binding protein 1 |
3476 |
P78318 |
chrX: 70,133,449-70,166,324 |
GTF2I |
general transcription factor IIi |
2969 |
P78347 |
chr7: 74,657,667-74,760,692 |
DLG4 |
discs, large homolog 4 (Drosophila) |
1742 |
P78352 |
chr17: 7,189,890-7,219,702 |
CCL20 |
chemokine (C-C motif) ligand 20 |
6364 |
P78556 |
chr2: 227,813,842-227,817,564 |
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3 |
3125 |
P79483 |
chr6: 32,444,128-32,457,245 |
CCL8 |
chemokine (C-C motif) ligand 8 |
6355 |
P80075 |
chr17: 34,319,036-34,321,402 |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
6372 |
P80162 |
chr4: 73,836,497-73,849,064 |
TNFAIP6 |
TNF alpha induced protein 6 |
7130 |
P98066 |
chr2: 151,357,592-151,380,048 |
VLDLR |
very low density lipoprotein receptor |
7436 |
P98155 |
chr9: 2,621,834-2,660,053 |
ATP2C1 |
ATPase, Ca++ transporting, type 2C, member 1 |
27032 |
P98194 |
chr3: 130,850,595-131,016,712 |
MPP1 |
membrane protein, palmitoylated 1 |
4354 |
Q00013 |
chrX: 154,778,684-154,821,007 |
NDP |
Norrie disease (pseudoglioma) |
4693 |
Q00604 |
chrX: 43,948,776-43,973,504 |
IL9R |
interleukin 9 receptor |
3581 |
Q01113 |
chrX: 155,997,581-156,010,817 |
CD83 |
CD83 molecule |
9308 |
Q01151 |
chr6: 14,117,256-14,136,918 |
IL5RA |
interleukin 5 receptor subunit alpha |
3568 |
Q01344 |
chr3: 3,066,326-3,126,613 |
IL1RL1 |
interleukin 1 receptor-like 1 |
9173 |
Q01638 |
chr2: 102,311,502-102,352,037 |
OCRL |
oculocerebrorenal syndrome of Lowe |
4952 |
Q01968 |
chrX: 129,539,849-129,592,561 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
CREM |
cAMP responsive element modulator |
1390 |
Q03060 |
chr10: 35,126,791-35,212,958 |
PLAUR |
plasminogen activator, urokinase receptor |
5329 |
Q03405 |
chr19: 43,646,095-43,670,547 |
KRT17 |
keratin 17, type I |
3872 |
Q04695 |
chr17: 41,619,437-41,624,842 |
TLE1 |
transducin like enhancer of split 1 |
7088 |
Q04724 |
chr9: 81,583,683-81,689,305 |
TLE3 |
transducin like enhancer of split 3 |
7090 |
Q04726 |
chr15: 70,047,790-70,098,176 |
CD164 |
CD164 molecule, sialomucin |
8763 |
Q04900 |
chr6: 109,366,514-109,382,457 |
PRKCD |
protein kinase C, delta |
5580 |
Q05655 |
chr3: 53,156,009-53,192,717 |
TYRO3 |
TYRO3 protein tyrosine kinase |
7301 |
Q06418 |
chr15: 41,557,675-41,583,586 |
KHDRBS1 |
KH domain containing, RNA binding, signal transduction associated 1 |
10657 |
Q07666 |
chr1: 32,013,829-32,060,850 |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
IL10RB |
interleukin 10 receptor subunit beta |
3588 |
Q08334 |
chr21: 33,266,358-33,310,187 |
PDE4C |
phosphodiesterase 4C |
5143 |
Q08493 |
chr19: 18,207,961-18,255,419 |
PLCXD2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
257068 |
Q0VAA5 |
chr3: 111,674,676-111,846,447 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
2059 |
Q12929 |
chr12: 15,620,158-15,882,329 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
288 |
Q12955 |
chr10: 60,026,298-60,733,490 |
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
TRAF1 |
TNF receptor associated factor 1 |
7185 |
Q13077 |
chr9: 120,902,393-120,929,173 |
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
5607 |
Q13163 |
chr15: 67,542,709-67,807,123 |
MAPK7 |
mitogen-activated protein kinase 7 |
5598 |
Q13164 |
chr17: 19,377,721-19,383,544 |
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
5062 |
Q13177 |
chr3: 196,739,857-196,832,647 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
868 |
Q13191 |
chr3: 105,655,461-105,869,552 |
PTK7 |
protein tyrosine kinase 7 (inactive) |
5754 |
Q13308 |
chr6: 43,076,268-43,161,719 |
MTA1 |
metastasis associated 1 |
9112 |
Q13330 |
chr14: 105,419,820-105,470,729 |
ITGB3BP |
integrin subunit beta 3 binding protein |
23421 |
Q13352 |
chr1: 63,440,770-63,593,721 |
PPP2R5C |
protein phosphatase 2 regulatory subunit B', gamma |
5527 |
Q13362 |
chr14: 101,761,798-101,927,989 |
PDE3B |
phosphodiesterase 3B |
5140 |
Q13370 |
chr11: 14,643,723-14,872,044 |
PDCL |
phosducin like |
5082 |
Q13371 |
chr9: 122,798,389-122,828,631 |
PDAP1 |
PDGFA associated protein 1 |
11333 |
Q13442 |
chr7: 99,392,048-99,408,829 |
IL18R1 |
interleukin 18 receptor 1 |
8809 |
Q13478 |
chr2: 102,311,529-102,398,775 |
NAE1 |
NEDD8 activating enzyme E1 subunit 1 |
8883 |
Q13564 |
chr16: 66,802,875-66,873,256 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
3705 |
Q13572 |
chr14: 92,936,914-93,116,320 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
10788 |
Q13576 |
chr5: 76,403,249-76,708,132 |
TP53BP2 |
tumor protein p53 binding protein 2 |
7159 |
Q13625 |
chr1: 223,779,899-223,845,972 |
ACVR2B |
activin A receptor type IIB |
93 |
Q13705 |
chr3: 38,453,851-38,493,142 |
ALCAM |
activated leukocyte cell adhesion molecule |
214 |
Q13740 |
chr3: 105,366,909-105,576,900 |
RAPGEF1 |
Rap guanine nucleotide exchange factor 1 |
2889 |
Q13905 |
chr9: 131,576,770-131,740,074 |
PDE7A |
phosphodiesterase 7A |
5150 |
Q13946 |
chr8: 65,717,510-65,842,322 |
CAMK1 |
calcium/calmodulin-dependent protein kinase I |
8536 |
Q14012 |
chr3: 9,757,342-9,769,992 |
ARHGEF7 |
Rho guanine nucleotide exchange factor 7 |
8874 |
Q14155 |
chr13: 111,114,559-111,305,737 |
SCARF1 |
scavenger receptor class F member 1 |
8578 |
Q14162 |
chr17: 1,633,858-1,645,747 |
GAS6 |
growth arrest specific 6 |
2621 |
Q14393 |
chr13: 113,820,549-113,864,067 |
GRB14 |
growth factor receptor bound protein 14 |
2888 |
Q14449 |
chr2: 164,492,812-164,621,848 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
4739 |
Q14511 |
chr6: 11,183,298-11,382,348 |
SPARCL1 |
SPARC like 1 |
8404 |
Q14515 |
chr4: 87,473,335-87,531,061 |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
3709 |
Q14571 |
chr12: 26,336,515-26,833,198 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3708 |
Q14643 |
chr3: 4,493,348-4,847,840 |
RASA3 |
RAS p21 protein activator 3 |
22821 |
Q14644 |
chr13: 113,977,783-114,132,611 |
PPP2R5D |
protein phosphatase 2 regulatory subunit B', delta |
5528 |
Q14738 |
chr6: 42,984,499-43,012,342 |
ARHGAP19 |
Rho GTPase activating protein 19 |
84986 |
Q14CB8 |
chr10: 97,222,173-97,292,673 |
EBP |
emopamil binding protein (sterol isomerase) |
10682 |
Q15125 |
chrX: 48,521,158-48,528,716 |
PRKD1 |
protein kinase D1 |
5587 |
Q15139 |
chr14: 29,576,479-30,191,898 |
PPP2R5A |
protein phosphatase 2 regulatory subunit B', alpha |
5525 |
Q15172 |
chr1: 212,285,537-212,361,863 |
PTGES3 |
prostaglandin E synthase 3 |
10728 |
Q15185 |
chr12: 56,663,341-56,688,408 |
NECTIN1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 |
Q15223 |
chr11: 119,623,408-119,729,084 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
5796 |
Q15262 |
chr6: 127,968,779-128,520,674 |
RASA2 |
RAS p21 protein activator 2 |
5922 |
Q15283 |
chr3: 141,487,047-141,615,342 |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
RALBP1 |
ralA binding protein 1 |
10928 |
Q15311 |
chr18: 9,475,009-9,538,116 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
6196 |
Q15349 |
chr6: 166,409,364-166,906,451 |
RHEB |
Ras homolog enriched in brain |
6009 |
Q15382 |
chr7: 151,466,012-151,520,120 |
TLR1 |
toll-like receptor 1 |
7096 |
Q15399 |
chr4: 38,790,677-38,856,817 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
6195 |
Q15418 |
chr1: 26,529,761-26,575,030 |
SHB |
Src homology 2 domain containing adaptor protein B |
6461 |
Q15464 |
chr9: 37,919,134-38,069,211 |
MAPRE2 |
microtubule associated protein RP/EB family member 2 |
10982 |
Q15555 |
chr18: 34,976,928-35,143,470 |
TRADD |
TNFRSF1A-associated via death domain |
8717 |
Q15628 |
chr16: 67,154,180-67,160,298 |
TRIP10 |
thyroid hormone receptor interactor 10 |
9322 |
Q15642 |
chr19: 6,737,925-6,751,526 |
SMAD1 |
SMAD family member 1 |
4086 |
Q15797 |
chr4: 145,481,194-145,558,079 |
ZYX |
zyxin |
7791 |
Q15942 |
chr7: 143,381,080-143,391,111 |
EXT1 |
exostosin glycosyltransferase 1 |
2131 |
Q16394 |
chr8: 117,794,490-118,111,853 |
PKN1 |
protein kinase N1 |
5585 |
Q16512 |
chr19: 14,433,053-14,471,867 |
PKN2 |
protein kinase N2 |
5586 |
Q16513 |
chr1: 88,684,222-88,836,255 |
MAPK14 |
mitogen-activated protein kinase 14 |
1432 |
Q16539 |
chr6: 36,027,677-36,111,236 |
DPYSL2 |
dihydropyrimidinase like 2 |
1808 |
Q16555 |
chr8: 26,514,022-26,658,178 |
CARTPT |
CART prepropeptide |
9607 |
Q16568 |
chr5: 71,719,163-71,721,048 |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
3091 |
Q16665 |
chr14: 61,695,513-61,748,259 |
AMHR2 |
anti-Mullerian hormone receptor, type II |
269 |
Q16671 |
chr12: 53,423,855-53,431,534 |
TXNRD1 |
thioredoxin reductase 1 |
7296 |
Q16881 |
chr12: 104,215,779-104,350,305 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
59269 |
Q5T1R4 |
chr1: 41,506,365-42,035,925 |
SFRP5 |
secreted frizzled-related protein 5 |
6425 |
Q5T4F7 |
chr10: 97,766,751-97,771,952 |
ARHGAP21 |
Rho GTPase activating protein 21 |
57584 |
Q5T5U3 |
chr10: 24,583,609-24,723,668 |
GKAP1 |
G kinase anchoring protein 1 |
80318 |
Q5VSY0 |
chr9: 83,739,421-83,829,516 |
PLCXD3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
345557 |
Q63HM9 |
chr5: 41,306,954-41,510,628 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
59307 |
Q6IA17 |
chr11: 405,716-417,455 |
OR52E8 |
olfactory receptor family 52 subfamily E member 8 |
390079 |
Q6IFG1 |
chr11: 5,856,674-5,857,734 |
TENM4 |
teneurin transmembrane protein 4 |
26011 |
Q6N022 |
chr11: 78,652,831-79,440,948 |
RGMB |
repulsive guidance molecule family member b |
285704 |
Q6NW40 |
chr5: 98,768,650-98,798,643 |
ARHGAP11A |
Rho GTPase activating protein 11A |
9824 |
Q6P4F7 |
chr15: 32,615,144-32,639,949 |
SARM1 |
sterile alpha and TIR motif containing 1 |
23098 |
Q6SZW1 |
chr17: 28,364,356-28,404,049 |
DTHD1 |
death domain containing 1 |
401124 |
Q6ZMT9 |
chr4: 36,281,622-36,345,756 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
166824 |
Q6ZTQ3 |
chr4: 73,571,550-73,620,631 |
SYDE1 |
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
85360 |
Q6ZW31 |
chr19: 15,107,403-15,114,988 |
RAPH1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
65059 |
Q70E73 |
chr2: 203,394,345-203,535,410 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
CXXC5 |
CXXC finger protein 5 |
51523 |
Q7LFL8 |
chr5: 139,647,299-139,683,882 |
PLPPR4 |
phospholipid phosphatase related 4 |
9890 |
Q7Z2D5 |
chr1: 99,263,953-99,309,590 |
ZFYVE16 |
zinc finger, FYVE domain containing 16 |
9765 |
Q7Z3T8 |
chr5: 80,408,013-80,479,350 |
MAVS |
mitochondrial antiviral signaling protein |
57506 |
Q7Z434 |
chr20: 3,846,799-3,876,123 |
ARHGAP22 |
Rho GTPase activating protein 22 |
58504 |
Q7Z5H3 |
chr10: 48,446,034-48,656,265 |
NET1 |
neuroepithelial cell transforming 1 |
10276 |
Q7Z628 |
chr10: 5,412,551-5,458,463 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
57522 |
Q7Z6B7 |
chr12: 63,844,293-64,162,221 |
TMED4 |
transmembrane p24 trafficking protein 4 |
222068 |
Q7Z7H5 |
chr7: 44,577,894-44,582,287 |
RASSF3 |
Ras association (RalGDS/AF-6) domain family member 3 |
283349 |
Q86WH2 |
chr12: 64,507,001-64,697,567 |
PDPN |
podoplanin |
10630 |
Q86YL7 |
chr1: 13,583,465-13,617,957 |
ZDHHC17 |
zinc finger, DHHC-type containing 17 |
23390 |
Q8IUH5 |
chr12: 76,763,588-76,853,696 |
NOSTRIN |
nitric oxide synthase trafficking |
115677 |
Q8IVI9 |
chr2: 168,786,539-168,865,514 |
SLC44A2 |
solute carrier family 44 (choline transporter), member 2 |
57153 |
Q8IWA5 |
chr19: 10,602,457-10,644,559 |
RTKN2 |
rhotekin 2 |
219790 |
Q8IZC4 |
chr10: 62,183,035-62,268,707 |
UNC5B |
unc-5 netrin receptor B |
219699 |
Q8IZJ1 |
chr10: 71,212,570-71,302,864 |
TAGAP |
T-cell activation RhoGTPase activating protein |
117289 |
Q8N103 |
chr6: 159,034,468-159,045,152 |
ARHGAP24 |
Rho GTPase activating protein 24 |
83478 |
Q8N264 |
chr4: 85,475,114-86,002,670 |
PLPP5 |
phospholipid phosphatase 5 |
84513 |
Q8NEB5 |
chr8: 38,263,130-38,269,243 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
55198 |
Q8NEU8 |
chr12: 105,173,296-105,236,238 |
GPRC5A |
G protein-coupled receptor, class C, group 5, member A |
9052 |
Q8NFJ5 |
chr12: 12,890,782-12,917,937 |
LILRB1 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 |
Q8NHL6 |
chr19: 54,617,158-54,637,528 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
11228 |
Q8NHQ8 |
chr12: 25,959,029-26,079,892 |
RIN3 |
Ras and Rab interactor 3 |
79890 |
Q8TB24 |
chr14: 92,513,774-92,688,994 |
C18orf32 |
chromosome 18 open reading frame 32 |
497661 |
Q8TCD1 |
chr18: 49,477,250-49,487,252 |
RHPN1 |
rhophilin, Rho GTPase binding protein 1 |
114822 |
Q8TCX5 |
chr8: 143,368,887-143,384,220 |
DLG5 |
discs, large homolog 5 (Drosophila) |
9231 |
Q8TDM6 |
chr10: 77,790,791-77,926,526 |
MICAL1 |
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
64780 |
Q8TDZ2 |
chr6: 109,444,062-109,465,968 |
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
6574 |
Q8WUM9 |
chr2: 112,645,857-112,663,827 |
SECTM1 |
secreted and transmembrane 1 |
6398 |
Q8WVN6 |
chr17: 82,321,024-82,334,074 |
ARAP3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
64411 |
Q8WWN8 |
chr5: 141,653,401-141,682,221 |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
116984 |
Q8WZ64 |
chr4: 35,948,221-36,244,509 |
STARD8 |
StAR related lipid transfer domain containing 8 |
9754 |
Q92502 |
chrX: 68,647,666-68,725,842 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
9806 |
Q92563 |
chr10: 72,059,035-72,089,032 |
NSMAF |
neutral sphingomyelinase activation associated factor |
8439 |
Q92636 |
chr8: 58,583,504-58,659,844 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
6653 |
Q92673 |
chr11: 121,452,203-121,633,693 |
ESR2 |
estrogen receptor 2 (ER beta) |
2100 |
Q92731 |
chr14: 64,084,232-64,338,112 |
TFG |
TRK-fused gene |
10342 |
Q92734 |
chr3: 100,709,331-100,748,966 |
STAM |
signal transducing adaptor molecule |
8027 |
Q92783 |
chr10: 17,644,125-17,715,914 |
CREBBP |
CREB binding protein |
1387 |
Q92793 |
chr16: 3,725,054-3,880,726 |
INPP5D |
inositol polyphosphate-5-phosphatase D |
3635 |
Q92835 |
chr2: 233,059,967-233,207,903 |
TANK |
TRAF family member associated NFKB activator |
10010 |
Q92844 |
chr2: 161,136,908-161,236,221 |
KIFAP3 |
kinesin-associated protein 3 |
22920 |
Q92845 |
chr1: 169,921,326-170,085,208 |
CDS1 |
CDP-diacylglycerol synthase 1 |
1040 |
Q92903 |
chr4: 84,582,979-84,651,338 |
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
RIT1 |
Ras-like without CAAX 1 |
6016 |
Q92963 |
chr1: 155,897,808-155,911,404 |
TNFRSF25 |
tumor necrosis factor receptor superfamily member 25 |
8718 |
Q93038 |
chr1: 6,461,151-6,466,195 |
EXT2 |
exostosin glycosyltransferase 2 |
2132 |
Q93063 |
chr11: 44,095,549-44,245,429 |
MR1 |
major histocompatibility complex, class I-related |
3140 |
Q95460 |
chr1: 181,033,425-181,061,938 |
ARRDC3 |
arrestin domain containing 3 |
57561 |
Q96B67 |
chr5: 91,368,724-91,383,359 |
OPTN |
optineurin |
10133 |
Q96CV9 |
chr10: 13,099,449-13,138,308 |
PLPPR2 |
phospholipid phosphatase related 2 |
64748 |
Q96GM1 |
chr19: 11,355,386-11,365,698 |
CDKN2AIPNL |
CDKN2A interacting protein N-terminal like |
91368 |
Q96HQ2 |
chr5: 134,402,087-134,411,898 |
ARAP1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
116985 |
Q96P48 |
chr11: 72,685,069-72,793,599 |
INPP4A |
inositol polyphosphate-4-phosphatase type I A |
3631 |
Q96PE3 |
chr2: 98,444,854-98,594,390 |
DLC1 |
DLC1 Rho GTPase activating protein |
10395 |
Q96QB1 |
chr8: 13,083,361-13,604,610 |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
9971 |
Q96RI1 |
chr12: 100,473,708-100,564,413 |
CSF3R |
colony stimulating factor 3 receptor |
1441 |
Q99062 |
chr1: 36,466,043-36,483,278 |
HBEGF |
heparin-binding EGF-like growth factor |
1839 |
Q99075 |
chr5: 140,332,843-140,346,631 |
STAC |
SH3 and cysteine rich domain |
6769 |
Q99469 |
chr3: 36,380,344-36,548,007 |
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
5025 |
Q99571 |
chr12: 121,209,857-121,234,106 |
DOK1 |
docking protein 1 |
1796 |
Q99704 |
chr2: 74,549,026-74,557,554 |
SMAD5 |
SMAD family member 5 |
4090 |
Q99717 |
chr5: 136,132,845-136,188,747 |
LITAF |
lipopolysaccharide-induced TNF factor |
9516 |
Q99732 |
chr16: 11,547,722-11,636,381 |
EPAS1 |
endothelial PAS domain protein 1 |
2034 |
Q99814 |
chr2: 46,293,667-46,386,703 |
SH3GL2 |
SH3-domain GRB2-like 2 |
6456 |
Q99962 |
chr9: 17,579,082-17,797,129 |
GDF15 |
growth differentiation factor 15 |
9518 |
Q99988 |
chr19: 18,374,731-18,389,176 |
SPOCK3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
50859 |
Q9BQ16 |
chr4: 166,733,384-167,234,796 |
NDFIP1 |
Nedd4 family interacting protein 1 |
80762 |
Q9BT67 |
chr5: 142,108,505-142,154,443 |
SALL3 |
spalt-like transcription factor 3 |
27164 |
Q9BXA9 |
chr18: 78,980,275-79,002,677 |
CD244 |
CD244 molecule, natural killer cell receptor 2B4 |
51744 |
Q9BZW8 |
chr1: 160,830,160-160,862,855 |
TOLLIP |
toll interacting protein |
54472 |
Q9H0E2 |
chr11: 1,274,371-1,309,654 |
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
11059 |
Q9H0M0 |
chr8: 86,342,738-86,478,420 |
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
53335 |
Q9H165 |
chr2: 60,451,167-60,553,567 |
RASSF4 |
Ras association (RalGDS/AF-6) domain family member 4 |
83937 |
Q9H2L5 |
chr10: 44,959,407-44,995,891 |
SMOC2 |
SPARC related modular calcium binding 2 |
64094 |
Q9H3U7 |
chr6: 168,441,151-168,673,445 |
SP110 |
Sp110 nuclear body protein |
3431 |
Q9HB58 |
chr2: 230,167,293-230,225,729 |
NEK6 |
NIMA-related kinase 6 |
10783 |
Q9HC98 |
chr9: 124,257,606-124,353,307 |
PDE7B |
phosphodiesterase 7B |
27115 |
Q9NP56 |
chr6: 135,851,696-136,195,574 |
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
KIF13B |
kinesin family member 13B |
23303 |
Q9NQT8 |
chr8: 29,067,279-29,263,124 |
DLL4 |
delta-like 4 (Drosophila) |
54567 |
Q9NR61 |
chr15: 40,929,340-40,939,072 |
CDC42SE1 |
CDC42 small effector 1 |
56882 |
Q9NRR8 |
chr1: 151,050,971-151,070,325 |
SNX15 |
sorting nexin 15 |
29907 |
Q9NRS6 |
chr11: 65,027,408-65,040,572 |
KCNIP2 |
Kv channel interacting protein 2 |
30819 |
Q9NS61 |
chr10: 101,825,974-101,843,920 |
GPR27 |
G protein-coupled receptor 27 |
2850 |
Q9NS67 |
chr3: 71,754,050-71,756,496 |
NDFIP2 |
Nedd4 family interacting protein 2 |
54602 |
Q9NV92 |
chr13: 79,481,124-79,556,075 |
PAG1 |
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 |
55824 |
Q9NWQ8 |
chr8: 80,967,810-81,112,068 |
SPHK1 |
sphingosine kinase 1 |
8877 |
Q9NYA1 |
chr17: 76,376,584-76,387,860 |
FAM13B |
family with sequence similarity 13 member B |
51306 |
Q9NYF5 |
chr5: 137,937,960-138,051,961 |
VAPA |
VAMP associated protein A |
9218 |
Q9P0L0 |
chr18: 9,914,002-9,960,021 |
ARHGAP23 |
Rho GTPase activating protein 23 |
57636 |
Q9P227 |
chr17: 38,419,280-38,512,392 |
TENM3 |
teneurin transmembrane protein 3 |
55714 |
Q9P273 |
chr4: 182,143,987-182,803,024 |
PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
57144 |
Q9P286 |
chr20: 9,537,389-9,839,041 |
ARHGAP20 |
Rho GTPase activating protein 20 |
57569 |
Q9P2F6 |
chr11: 110,577,042-110,713,189 |
PI4KB |
phosphatidylinositol 4-kinase, catalytic, beta |
5298 |
Q9UBF8 |
chr1: 151,291,797-151,327,715 |
RNF14 |
ring finger protein 14 |
9604 |
Q9UBS8 |
chr5: 141,958,328-141,990,291 |
LIMD1 |
LIM domains containing 1 |
8994 |
Q9UGP4 |
chr3: 45,555,394-45,686,338 |
ASIC3 |
acid sensing ion channel subunit 3 |
9311 |
Q9UHC3 |
chr7: 151,048,292-151,052,756 |
LNPEP |
leucyl/cystinyl aminopeptidase |
4012 |
Q9UIQ6 |
chr5: 96,935,394-97,037,515 |
CNOT7 |
CCR4-NOT transcription complex subunit 7 |
29883 |
Q9UIV1 |
chr8: 17,224,964-17,246,878 |
PITPNC1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
26207 |
Q9UKF7 |
chr17: 67,377,281-67,697,261 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
10602 |
Q9UKI2 |
chr2: 37,641,882-37,738,468 |
PILRA |
paired immunoglobin-like type 2 receptor alpha |
29992 |
Q9UKJ1 |
chr7: 100,367,530-100,400,099 |
AMFR |
autocrine motility factor receptor, E3 ubiquitin protein ligase |
267 |
Q9UKV5 |
chr16: 56,361,452-56,425,538 |
INTS6 |
integrator complex subunit 6 |
26512 |
Q9UL03 |
chr13: 51,354,077-51,454,264 |
MKLN1 |
muskelin 1 |
4289 |
Q9UL63 |
chr7: 131,110,096-131,496,636 |
CORO1C |
coronin, actin binding protein, 1C |
23603 |
Q9ULV4 |
chr12: 108,645,109-108,731,596 |
APLN |
apelin |
8862 |
Q9ULZ1 |
chrX: 129,645,259-129,654,937 |
PYCARD |
PYD and CARD domain containing |
29108 |
Q9ULZ3 |
chr16: 31,201,485-31,203,450 |
HPCAL4 |
hippocalcin like 4 |
51440 |
Q9UM19 |
chr1: 39,678,648-39,691,689 |
SUFU |
suppressor of fused homolog (Drosophila) |
51684 |
Q9UMX1 |
chr10: 102,503,987-102,633,535 |
NDRG2 |
NDRG family member 2 |
57447 |
Q9UN36 |
chr14: 21,016,763-21,070,872 |
ARHGAP26 |
Rho GTPase activating protein 26 |
23092 |
Q9UNA1 |
chr5: 142,770,384-143,229,011 |
SMC3 |
structural maintenance of chromosomes 3 |
9126 |
Q9UQE7 |
chr10: 110,567,691-110,604,636 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
PLAA |
phospholipase A2-activating protein |
9373 |
Q9Y263 |
chr9: 26,904,083-26,947,463 |
RASD1 |
RAS, dexamethasone-induced 1 |
51655 |
Q9Y272 |
chr17: 17,494,437-17,496,395 |
TNFSF13B |
tumor necrosis factor superfamily member 13b |
10673 |
Q9Y275 |
chr13: 108,251,240-108,308,484 |
BTRC |
beta-transducin repeat containing E3 ubiquitin protein ligase |
8945 |
Q9Y297 |
chr10: 101,354,033-101,557,321 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
11142 |
Q9Y2B9 |
chr20: 44,531,785-44,624,247 |
GOLT1B |
golgi transport 1B |
51026 |
Q9Y3E0 |
chr12: 21,501,781-21,518,408 |
STARD13 |
StAR related lipid transfer domain containing 13 |
90627 |
Q9Y3M8 |
chr13: 33,103,135-33,350,630 |
HBS1L |
HBS1 like translational GTPase |
10767 |
Q9Y450 |
chr6: 134,960,378-135,103,056 |
IRS2 |
insulin receptor substrate 2 |
8660 |
Q9Y4H2 |
chr13: 109,752,698-109,786,568 |
DTNA |
dystrobrevin alpha |
1837 |
Q9Y4J8 |
chr18: 34,493,290-34,891,844 |
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
9578 |
Q9Y5S2 |
chr14: 102,932,379-103,057,462 |
WIF1 |
WNT inhibitory factor 1 |
11197 |
Q9Y5W5 |
chr12: 65,050,626-65,121,566 |
LYVE1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
10894 |
Q9Y5Y7 |
chr11: 10,556,966-10,611,689 |
STK24 |
serine/threonine kinase 24 |
8428 |
Q9Y6E0 |
chr13: 98,445,185-98,577,940 |
CSNK1G3 |
casein kinase 1, gamma 3 |
1456 |
Q9Y6M4 |
chr5: 123,512,099-123,617,045 |
TNFRSF11A |
tumor necrosis factor receptor superfamily member 11a |
8792 |
Q9Y6Q6 |
chr18: 62,325,287-62,391,292 |